Log in to save to my catalogue

Compared to the amniotic membrane, Wharton's jelly may be a more suitable source of mesenchymal stem...

Compared to the amniotic membrane, Wharton's jelly may be a more suitable source of mesenchymal stem...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5359832

Compared to the amniotic membrane, Wharton's jelly may be a more suitable source of mesenchymal stem cells for cardiovascular tissue engineering and clinical regeneration

About this item

Full title

Compared to the amniotic membrane, Wharton's jelly may be a more suitable source of mesenchymal stem cells for cardiovascular tissue engineering and clinical regeneration

Publisher

England: BioMed Central

Journal title

Stem cell research & therapy, 2017-03, Vol.8 (1), p.72-72, Article 72

Language

English

Formats

Publication information

Publisher

England: BioMed Central

More information

Scope and Contents

Contents

The success of developing cardiovascular tissue engineering (CTE) grafts greatly needs a readily available cell substitute for endothelial and interstitial cells. Perinatal annexes have been proposed as a valuable source of mesenchymal stem cells (MSCs) for tissue engineering and regenerative medicine. The objective of the present study is to evalu...

Alternative Titles

Full title

Compared to the amniotic membrane, Wharton's jelly may be a more suitable source of mesenchymal stem cells for cardiovascular tissue engineering and clinical regeneration

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5359832

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5359832

Other Identifiers

ISSN

1757-6512

E-ISSN

1757-6512

DOI

10.1186/s13287-017-0501-x

How to access this item